title: Checkpoint Inhibitors in Lung Cancer Are Not Immune from Cost-Effectiveness Analysis.
authors: Department of Thoracic Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Electronic address: Rkelly25@jhmi.edu.
authors: Ronan J
authors: RJ
authors: Kelly
authors: Department of Thoracic Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
authors: Thomas J
authors: TJ
authors: Smith
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung; D003362:Cost-Benefit Analysis; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor
chemical_list: D061026:Programmed Cell Death 1 Receptor